List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use | No observations |
PAHO Strategic Fund Medicine List | 13.4. Medicines used for disorders due to psychoactive substance use | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use | No observations |
PAHO Strategic Fund Medicine List | 13.4. Medicines used for disorders due to psychoactive substance use | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use | No observations |
PAHO Strategic Fund Medicine List | 13.4. Medicines used for disorders due to psychoactive substance use | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use | No observations |
PAHO Strategic Fund Medicine List | 13.4. Medicines used for disorders due to psychoactive substance use | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use | No observations |